BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38679790)

  • 1. S1-Guideline Sebaceous Carcinoma.
    Utikal J; Nagel P; Müller V; Becker JC; Dippel E; Frisman A; Gschnell M; Griewank K; Hadaschik E; Helbig D; Hillen U; Leiter U; Pföhler C; Krönig L; Ziemer M; Ugurel S
    J Dtsch Dermatol Ges; 2024 May; 22(5):730-747. PubMed ID: 38679790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Utikal J; Nagel P; Müller V; Becker JC; Dippel E; Frisman A; Gschnell M; Griewank K; Hadaschik E; Helbig D; Hillen U; Leiter U; Pföhler C; Krönig L; Ziemer M; Ugurel S
    J Dtsch Dermatol Ges; 2024 May; 22(5):730-749. PubMed ID: 38730519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sebaceous Neoplasms.
    Flux K
    Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surgery and adjuvant treatment on the outcome of extraocular sebaceous carcinoma: a systematic review and individual patient's data analysis of 206 cases.
    Giridhar P; Kashyap L; Mallick S; Dutt Upadhyay A; Rath GK
    Int J Dermatol; 2020 Apr; 59(4):494-505. PubMed ID: 31850516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraocular sebaceous carcinoma: a report of 2 cases.
    Cieza-Díaz DE; Cano-Martínez N; Barchino-Ortiz L; Longo-Imedio I
    Actas Dermosifiliogr; 2012 Dec; 103(10):919-22. PubMed ID: 23149052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.
    Neelakantan IV; Di Palma S; Smith CE; McCoombe A
    Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment.
    Buitrago W; Joseph AK
    Dermatol Ther; 2008; 21(6):459-66. PubMed ID: 19076624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management Considerations in Extraocular Sebaceous Carcinoma.
    Chang AY; Miller CJ; Elenitsas R; Newman JG; Sobanko JF
    Dermatol Surg; 2016 Jan; 42 Suppl 1():S57-65. PubMed ID: 26730975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sebaceous Carcinoma: A Review of the Scientific Literature.
    Knackstedt T; Samie FH
    Curr Treat Options Oncol; 2017 Aug; 18(8):47. PubMed ID: 28681210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deceptively Innocent Façade of Sebaceous Carcinoma in Muir-Torre Syndrome.
    Cox SV; Smith J
    Dermatol Surg; 2021 Jun; 47(6):828-829. PubMed ID: 33038102
    [No Abstract]   [Full Text] [Related]  

  • 11. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
    Harrington CR; Egbert BM; Swetter SM
    Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma.
    Ivan D; Prieto VG; Esmaeli B; Wistuba II; Tang X; Lazar AJ
    J Cutan Pathol; 2010 Feb; 37(2):231-6. PubMed ID: 19614729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.
    Shalin SC; Lyle S; Calonje E; Lazar AJ
    Histopathology; 2010 Jan; 56(1):133-47. PubMed ID: 20055911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic Prostatic Adenocarcinoma in Patient With Muir-Torre Syndrome Misdiagnosed as Metastatic Sebaceous Carcinoma: Case Report and Systematic Literature Review.
    Cattelan L; Abi-Rafeh J; Brimo F; Kazan R; Redpath M; Chergui M
    Am J Dermatopathol; 2020 Sep; 42(9):700-705. PubMed ID: 32568842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sebaceous lesions of the skin.
    Iacobelli J; Harvey NT; Wood BA
    Pathology; 2017 Dec; 49(7):688-697. PubMed ID: 29078997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
    Cook S; Pethick J; Kibbi N; Hollestein L; Lavelle K; de Vere Hunt I; Turnbull C; Rous B; Husain A; Burn J; Lüchtenborg M; Santaniello F; McRonald F; Hardy S; Linos E; Venables Z; Rajan N
    J Am Acad Dermatol; 2023 Dec; 89(6):1129-1135. PubMed ID: 37031776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muir-Torre Syndrome in a Middle-Aged Chinese Patient with Sebaceous Carcinoma of the Eyelid.
    Wong CY; Tang RK; Lam RF; Io IY; Yuen CY; Ho JW; Tse RK
    Semin Ophthalmol; 2015; 30(5-6):420-2. PubMed ID: 24117411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genitourinary tumors in men with the Muir-Torre syndrome.
    Davis DA; Cohen PR
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):909-12. PubMed ID: 7593809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraocular well-differentiated sebaceous tumors with overlying cutaneous horns: four tumors in three patients.
    Jhuang JY; Liao SL; Tsai JH; Chang HC; Kuo KT; Liau JY
    J Cutan Pathol; 2014 Aug; 41(8):650-6. PubMed ID: 24548110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
    Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P
    Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.